SEER

Seer, Inc. NASDAQ Listed Dec 4, 2020

Healthcare ·Biotechnology ·US · seer.bio

$1.88

Mkt Cap $106.1M

52w Low $1.65 30.3% of range 52w High $2.41

50d MA $1.83 200d MA $1.98

P/E (TTM) -1.6x

EV/EBITDA -1.2x

P/B 0.5x

Debt/Equity 0.1x

ROE -28.4%

P/FCF -2.3x

RSI (14) —

ATR (14) —

Beta 1.60

50d MA $1.83

200d MA $1.98

Avg Volume 382.9K

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

SIC Code

3826

CIK (SEC)

1726445

Phone

650 453 0000

3800 Bridge Parkway · Redwood City, CA 94065 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 26, 2026	AMC	-0.32	-0.29	+9.4%	2.08	-15.4%	-17.3%	-16.8%	-13.5%	-11.1%	-11.5%	—
Nov 6, 2025	AMC	-0.32	-0.32	+0.0%	2.16	-0.9%	-3.2%	-3.2%	-4.2%	-3.7%	-5.6%	—
Aug 6, 2025	AMC	-0.39	-0.33	+15.4%	2.06	+0.5%	-2.4%	+11.7%	+7.3%	+6.8%	+5.3%	—
May 13, 2025	AMC	-0.37	-0.34	+8.1%	1.92	+9.9%	+9.9%	+8.3%	+7.8%	+7.8%	+8.9%	—
Feb 27, 2025	AMC	-0.31	-0.34	-9.7%	2.20	+0.0%	-4.5%	-6.4%	-7.3%	-7.3%	-9.1%	—
Nov 6, 2024	AMC	-0.29	-0.34	-17.2%	2.07	-2.4%	+7.2%	+15.0%	+8.2%	+9.2%	+11.6%	—
Aug 8, 2024	AMC	-0.36	-0.35	+2.8%	1.73	-0.6%	-0.6%	-1.7%	-1.7%	-4.0%	-2.3%	—
May 8, 2024	AMC	-0.31	-0.32	-3.2%	2.23	-6.7%	-7.6%	-10.3%	-10.8%	-3.1%	-4.0%	—
Feb 29, 2024	AMC	-0.35	-0.28	+20.0%	1.82	-1.1%	+0.0%	+5.5%	+4.9%	+10.4%	+14.3%	—
Nov 7, 2023	AMC	-0.38	-0.33	+13.2%	1.72	-4.1%	-5.2%	-6.1%	-9.3%	-7.6%	-3.5%	—
Aug 8, 2023	AMC	-0.38	-0.37	+2.6%	4.66	-4.5%	-33.7%	-40.1%	-41.0%	-39.7%	-42.3%	—
May 9, 2023	AMC	-0.37	-0.38	-2.7%	3.64	-0.8%	-4.4%	-9.3%	-13.2%	-9.3%	-11.0%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 4	Canaccord Genuity	Initiates	Buy	$4	$2.03	$2.05	+1.0%	-3.9%	-8.4%	-6.9%	-7.4%	—
Aug 13	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$1.70	$1.70	+0.0%	+0.0%	-2.4%	-0.6%	-0.6%	-2.4%
Feb 21	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$4.44	$4.14	-6.8%	-11.3%	-10.6%	-11.5%	-16.2%	-11.9%
Jan 4	BofA Securities	Downgrade	Neutral → Underperform	—	$5.85	$5.52	-5.6%	-22.1%	-27.5%	-21.4%	-13.8%	-3.1%
Nov 10	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$6.79	$7.16	+5.4%	+20.3%	+26.4%	+15.2%	+20.9%	+9.9%
Aug 11	JP Morgan	Downgrade	Overweight → Neutral	—	$13.31	$12.28	-7.7%	-19.7%	-10.5%	-11.3%	-18.0%	-18.0%
Aug 11	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$13.31	$12.28	-7.7%	-19.7%	-10.5%	-11.3%	-18.0%	-18.0%
May 5	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$9.04	$8.91	-1.4%	-0.4%	+2.8%	-11.1%	-14.7%	-22.3%
Mar 1	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$15.32	$14.85	-3.1%	-10.0%	-9.7%	-14.0%	-18.4%	-21.7%
Feb 15	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$15.41	$15.89	+3.1%	+3.9%	+1.6%	-8.2%	-16.9%	-16.7%
Aug 13	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$29.85	$29.32	-1.8%	+8.8%	+1.9%	-0.3%	-1.1%	+0.5%
May 12	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$31.96	$31.13	-2.6%	-10.0%	-9.9%	-7.4%	-3.6%	+0.0%
Mar 30	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$41.05	$40.65	-1.0%	+5.3%	+21.9%	+27.1%	+38.5%	+33.9%
Dec 29	Cowen & Co.	Maintains	Outperform → Outperform	—	$64.40	$63.99	-0.6%	-14.2%	-12.3%	-12.8%	-16.1%	-9.8%
Dec 29	JP Morgan	Maintains	Overweight → Overweight	—	$64.40	$63.99	-0.6%	-14.2%	-12.3%	-12.8%	-16.1%	-9.8%
Dec 29	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$64.40	$63.99	-0.6%	-14.2%	-12.3%	-12.8%	-16.1%	-9.8%

Data updated apr 27, 2026 12:39am · Source: massive.com